Parirenyatwa trial: NatPham manager testifies  - Zimbabwe Situation

Parirenyatwa trial: NatPham manager testifies 

Source: Parirenyatwa trial: NatPham manager testifies | The Herald February 9, 2019

Parirenyatwa trial: NatPham manager testifies
Dr Parirenyatwa

Panashe Machakaire Herald Reporter
Former Health and Child Care Minister David Parirenyatwa caused double dipping at the National Pharmaceutical Company (NatPharm) when he ordered unilateral appointments, the court heard yesterday.

Parirenyatwa is facing charges of criminal abuse of office emanating from the orders he gave to the pharmaceutical company’s board.

He is being accused of ordering NatPharm board chairman Dr George Washaya to terminate Ms Flora Nancy Sifeku’s contract as managing director of the company on the basis that he required her services at the Ministry.

He also directed Dr Washaya to appoint Newman Madzikwa as the acting managing director of NatPharm with effect from June 1, 2018.

The board complied with the directive, resulting in Ms Sifeku and Mr Madzikwa both being given six-month contracts with effect from June to November 30, 2018.

NatPharm human resources manager Mr Walter Nhau, a State witness, told the Harare Magistrates’ Court that the scenario had negative implications on NatPham’s finances, which had no provision for two managing directors.

“We were advised by the board that Ms Sifeku was coming back,” he said.

“She was supposed to retire, but instead her contract was extended by six months. The arrangement affected NatPharm because it does not have provision for two managing directors.

“From June 1 to November 30, NatPharm was paying two managing directors. I can give you a rough estimate, by the end of August a total of $34 000 had been paid to Ms Sifeku and $16 000 to Mr Madzikwa.”

During cross examination, Parirenyatwa’s lawyer asked Mr Nhau whether he was aware that Ms Sifeku abused two employees in April last year which led to her being replaced by Mr  Madzikwa.

Mr Nhau said he heard about the allegations, but did not know how the matter ended.

The trial continues next Tuesday.

COMMENTS

WORDPRESS: 0